Hiromichi Kanehiro

4.2k total citations · 1 hit paper
102 papers, 3.4k citations indexed

About

Hiromichi Kanehiro is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Hiromichi Kanehiro has authored 102 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 33 papers in Oncology and 29 papers in Hepatology. Recurrent topics in Hiromichi Kanehiro's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Hiromichi Kanehiro is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Hiromichi Kanehiro collaborates with scholars based in Japan, United States and Canada. Hiromichi Kanehiro's co-authors include Yoshiyuki Nakajima, Masayuki Sho, Michiyoshi Hisanaga, Hiroshige Nakano, Takeo Nomi, Naoya Ikeda, Mitsuo Nagao, Saiho Ko, Hideo Yagita∥ and Takahiro Akahori and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hiromichi Kanehiro

95 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

2007 729 citations Takeo Nomi, Masayuki Sho et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiromichi Kanehiro Japan	29	1.5k	1.4k	723	712	642	102	3.4k
Minoru Kitago Japan	30	1.9k 1.2×	1.1k 0.8×	566 0.8×	1.1k 1.5×	498 0.8×	191	3.8k
Kuan‐Der Lee Taiwan	27	945 0.6×	1.4k 1.1×	480 0.7×	1.5k 2.2×	335 0.5×	98	4.1k
John Slavin Australia	30	1.1k 0.7×	794 0.6×	497 0.7×	997 1.4×	316 0.5×	78	3.5k
Taira Maekawa Japan	45	1.5k 1.0×	1.0k 0.8×	405 0.6×	1.9k 2.6×	1.2k 1.8×	224	5.6k
Takehiro Noda Japan	33	1.1k 0.7×	873 0.6×	729 1.0×	1.5k 2.1×	277 0.4×	207	3.3k
Masahiro Tanemura Japan	35	1.3k 0.8×	1.9k 1.4×	495 0.7×	2.2k 3.1×	427 0.7×	222	4.8k
Osamu Itano Japan	26	964 0.6×	1.2k 0.9×	980 1.4×	347 0.5×	132 0.2×	136	2.5k
Eishi Nagai Japan	37	1.9k 1.2×	1.3k 1.0×	231 0.3×	1.6k 2.3×	374 0.6×	111	4.2k
Fred Fändrich Germany	30	574 0.4×	868 0.6×	261 0.4×	1.2k 1.7×	633 1.0×	114	2.8k
Chang Ohk Sung South Korea	33	1.8k 1.1×	749 0.6×	183 0.3×	1.4k 2.0×	393 0.6×	142	4.0k

Countries citing papers authored by Hiromichi Kanehiro

Since Specialization

Citations

This map shows the geographic impact of Hiromichi Kanehiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromichi Kanehiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromichi Kanehiro more than expected).

Fields of papers citing papers by Hiromichi Kanehiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromichi Kanehiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromichi Kanehiro. The network helps show where Hiromichi Kanehiro may publish in the future.

Co-authorship network of co-authors of Hiromichi Kanehiro

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromichi Kanehiro. A scholar is included among the top collaborators of Hiromichi Kanehiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromichi Kanehiro. Hiromichi Kanehiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sho, Masayuki, Toshio Sawai, Hiromichi Kanehiro, et al.. (2020). Potential role of the PD-L1 expression and tumor-infiltrating lymphocytes on neuroblastoma. Pediatric Surgery International. 36(2). 137–143. 17 indexed citations

Hokuto, Daisuke, Takeo Nomi, Satoshi Yasuda, et al.. (2017). Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface?. Surgery. 163(2). 285–290. 15 indexed citations

Hokuto, Daisuke, Takeo Nomi, Ichiro Yamato, et al.. (2016). The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy. Journal of Surgical Oncology. 114(8). 959–965. 13 indexed citations

Hokuto, Daisuke, Takeo Nomi, Takahiro Yoshikawa, et al.. (2016). The Administration of Celecoxib as an Analgesic after Liver Resection Is Safe. Digestive Surgery. 34(2). 108–113. 6 indexed citations

Ueda, Takeshi, Takatsugu Yamada, Daisuke Hokuto, et al.. (2009). Generation of functional gut-like organ from mouse induced pluripotent stem cells. Biochemical and Biophysical Research Communications. 391(1). 38–42. 34 indexed citations

Nomi, Takeo, Masayuki Sho, Takahiro Akahori, et al.. (2007). Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer. Clinical Cancer Research. 13(7). 2151–2157. 729 indexed citations breakdown →

Tatekawa, Yukihiro, Takashi Tojo, Hiromichi Kanehiro, & Yoshiyuki Nakajima. (2007). Multistage Approach for Tracheobronchomalacia Caused by a Chest Deformity in the Setting of Severe Scoliosis. Surgery Today. 37(10). 910–914. 6 indexed citations

Nomi, Takeo, Masayuki Sho, Takahiro Akahori, et al.. (2006). Clinical significance and therapeutic potential of PD-L/PD-1 pathway in human pancreatic cancer. Cancer Research. 66. 96–96. 2 indexed citations

Ko, Saiho, Hiromichi Kanehiro, Masanori Matsumoto, et al.. (2006). Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: Observations in 3 cases. Liver Transplantation. 12(5). 859–869. 32 indexed citations

10.

Tsurui, Yoshikazu, Masayuki Sho, Kaoru Hamada, et al.. (2005). Dual Role of Vascular Endothelial Growth Factor in Hepatic Ischemia-Reperfusion Injury. Transplantation. 79(9). 1110–1115. 40 indexed citations

11.

Fukumoto, Akihisa, Naoya Ikeda, Masayuki Sho, et al.. (2004). Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncology Reports. 11(2). 277–84. 57 indexed citations

12.

Hayashi, Yukiko, Midori Shima, Hiromichi Kanehiro, et al.. (2004). Ecthyma gangrenosum combined with multiple perforations of the small intestine associated with Pseudomonas aeruginosa. Pediatrics International. 46(1). 104–108. 5 indexed citations

13.

Matsumoto, Hiroshi, Mitsuo Nagao, Hiromichi Kanehiro, et al.. (2003). Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.. PubMed. 23(2B). 1333–41. 20 indexed citations

14.

Kobayashi, Tsunehiro, Yukio Aomatsu, Hiroo Iwata, et al.. (2003). Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression1. Transplantation. 75(5). 619–625. 72 indexed citations

15.

Nakajima, Yoshiyuki, Mitsuo Nagao, Saiho Ko, et al.. (2002). Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer.. PubMed. 48(42). 1680–4. 23 indexed citations

16.

Nagao, Mitsuo, Hiromichi Kanehiro, Michiyoshi Hisanaga, et al.. (2001). PROGNOSTIC SIGNIFICANCE OF p21 AND p53 EXPRESSION IN HEPATOCELLULAR CARCINOMA. 52(2). 61–69. 1 indexed citations

17.

Kobayashi, Tsunehiro, Yoshiyuki Nakajima, Hiromichi Kanehiro, et al.. (1997). A Case Report of Ectopic Primary Hepatocellular Carcinoma Originated in the Ligamentum Teres Hepatis.. The Japanese Journal of Gastroenterological Surgery. 30(5). 1004–1008. 2 indexed citations

18.

Nakajima, Yoshiyuki, et al.. (1995). A Resected Case of Arteriovenous Malformation at the Pancreas Head.. The Japanese Journal of Gastroenterological Surgery. 28(5). 1090–1094. 3 indexed citations

19.

Hisanaga, Michiyoshi, Yoshiyuki Nakajima, Hiromichi Kanehiro, et al.. (1994). Significance of Prostaglandin E1 Administration on Hepatic Hemodynamics during Cirrhotic Liver Resection.. The Japanese Journal of Gastroenterological Surgery. 27(5). 1021–1027. 3 indexed citations

20.

Hisanaga, Michiyoshi, Yoshiyuki Nakajima, Hiromichi Kanehiro, et al.. (1991). Changes of Immunological Function after Hepatectomy in Patients with Malignant Liver Tumors.. The Japanese Journal of Gastroenterological Surgery. 24(12). 2926–2936. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact